Harel Insurance Investments & Financial Services’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-250,000	Closed	-$1.31M	–	538
2019 Q1	$1.31M	Hold	250,000	–	–	0.08%	69
2018 Q4	$383K	Sell	250,000 -300,000	-55%	-$1.07M	0.02%	126
2018 Q3	$2.23M	Hold	550,000	–	–	0.11%	76
2018 Q2	$2.15M	Hold	550,000	–	–	0.11%	68
2018 Q1	$1.9M	Hold	550,000	–	–	0.11%	77
2017 Q4	$361K	Buy	550,000 +300,000	+120%	+$2.08M	0.02%	163
2017 Q3	$145K	Buy	+250,000	New	+$1.6M	0.01%	214

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Nottingham Advisors Amherst, New York $838M AUM 15.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HWA

Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harel Insurance Investments & Financial Services's PLXP Position: Q2 2019 in Review

Harel Insurance Investments & Financial Services sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2019, closing a stake of 250,000 shares — an estimated $1.31M sold.

Harel Insurance Investments & Financial Services first reported a position in PLXP in Q3 2017 and held it in 7 quarters. The position peaked at $2.23M in Q3 2018. 18 funds tracked by Wall St. Rank hold PLXP as of Q2 2019.

Harel Insurance Investments & Financial Services reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 250,000 PLx Pharma Inc. Common Stock shares in Q2 2019, an estimated $1.31M.
Harel Insurance Investments & Financial Services first reported a position in PLx Pharma Inc. Common Stock in Q3 2017 and held it in 7 quarters.
Harel Insurance Investments & Financial Services's PLx Pharma Inc. Common Stock position peaked at $2.23M in Q3 2018.
18 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2019, filed 22 Jul 2019.